The Eye of the Storm: The Role of the Pharmacist during COVID-19

This on-demand module will educate pharmacists on opportunities for their involvement in prevention and treatment of COVID-19 infections. It will cover case-studies on how pharmacies managed the novel infectious disease, review current guidelines and best practices for the care of patients with COVID-19, diagnostic testing, and vaccine updates as of March 2022. Learners will be able to bring up to date recommendations from the literature and lessons learned from real world experience back to their practice sites and improve pharmacy practice and patient outcomes.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Describe two strategies used during COVID-19 surges to mitigate drug shortages in a health-system setting.
  • Explain three steps one hospital took to prevent transmission of COVID-19 infection to staff and patients.
  • Given a patient case and a mock protocol, select the most appropriate drug therapy regimen for a patient with COVID-19.
  • Describe the types of diagnostic tests for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV2) used in a community/ambulatory care pharmacy setting.
  • Provide the most up to date information on vaccines for Coronavirus-19 Disease (COVID-19).

Presenters

Sheila Seed, PharmD, RPh, MPH | Professor and Chair, Department of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences

Nathan Cookson, PharmD | Clinical Pharmacy Coordinator, Antimicrobial Stewardship
Saint Vincent Hospital

Registration Fee: Free for MCPHS alumni and full-time employees; $12.00 for all other professionals. Registration is required to earn ACPE credit.

Release Date: March 07, 2022
Expiration Date: March 21, 2023
ACPE UAN: : 0026-0000-22-102-H04-P | Application
Contact Hour: 1.0 (0.1 CEU)
Topic Designator: Pharmacy Administration

Accreditation Council for Pharmacy Education Logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this activity for a total of 1.0 contact hour (0.1 CEUs).

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Nathan Cookson and Sheila Seed have no relevant financial relationships with ineligible companies to disclose.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.